205 results on '"Luce, Amalia"'
Search Results
2. Immune cell infiltration and inflammatory landscape in primary brain tumours
3. Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
4. MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
5. Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
6. A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer
7. Mitochondria as playmakers of apoptosis, autophagy and senescence
8. miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma
9. miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma
10. Whey Improves In Vitro Endothelial Mitochondrial Function and Metabolic Redox Status in Diabetic State
11. Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus
12. Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures
13. Basal Cell Carcinoma: Molecular and Pathological Features
14. A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells
15. Characterization of KRAS Mutational Regression in Oligometastatic Patients
16. Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation
17. Additional file 2 of MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
18. Endocrine disruptors and female cancer: Informing the patients (Review)
19. A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells.
20. Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis
21. Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans
22. Polydatin Induces Differentiation and Radiation Sensitivity in Human Osteosarcoma Cells and Parallel Secretion through Lipid Metabolite Secretion
23. The Art of Counselling in the Treatment of Head and Neck Cancer: Explorative Investigation Among Perceptions of Health Professionals in Southern Italy.
24. Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade
25. Basal Cell Carcinoma: Molecular and Pathological Features
26. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer
27. KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
28. Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?
29. LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides
30. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
31. Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
32. On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
33. Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?
34. HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
35. Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
36. Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade
37. Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact
38. Correlation of HLA-B*35 and DRB1*11 alleles with a high risk of interstitial aseptic pneumonitis in cancer patients receiving PD-1/PDL1 immune-checkpoint blockade.
39. Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus.
40. Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide.
41. Additional file 1: of Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures
42. Additional file 3: of Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures
43. Additional file 2: of Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures
44. Comparative Study of NGS Platform Ion Torrent Personal Genome Machine and Therascreen Rotor-Gene Q for the Detection of Somatic Variants in Cancer
45. Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells
46. Radiomics predicts survival of patients with advanced non‑small cell lung cancer undergoing PD‑1 blockade using Nivolumab
47. Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience
48. Efficacy and Safety of Cetuximab plus Radiotherapy in Cisplatin-Unfit Elderly Patients with Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Study
49. Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug
50. Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.